Contact Us

TOURISM NEWS

Coway Announces Financial Results for Q4 and FY2024

Feb 17, 2025

Coway\'s 2024 Q4 revenue reached KRW 1,125.7 billion (+12.1% YoY) with an operating profit amounted to KRW 183.4 billion (+10.4% YoY)

BUYING SQUARE Launches Global Service for 'Catalog Shop,' Its Brand Wholesale Platform

Feb 17, 2025

SEOUL,South Korea,Feb. 14,2025--BUYING SQUARE,a next-generation digital wholesale platform,has announced the global launch of Catalog Shop,a B2B solution designed to streamline wholesale transactions

IASO Bio Announces Acceptance of New Drug Application for Equecabtagene Autoleucel (FUCASO) by the Hong Kong Department of Health

Feb 17, 2025

SHANGHAI and NANJING,China and SAN JOSE,Calif.,Feb. 14,2025-- IASO Biotherapeutics ("IASO Bio"),a biopharmaceutical company focused on the discovery,development,manufacturing,and commerciali

China Telecom's Asia Direct Cable (ADC) Capacity Enters Service Ahead of Schedule, Bolstering Regional Economic Development

Feb 17, 2025

HONG KONG,Feb. 14,2025-- On February 14,2025,China Telecom officially announced that the capacity of the Asia Direct Cable (ADC),an international submarine cable initiative led by China Telecom,has be

Polyplastics Launches New Eco-friendly PLASTRON (R) ︎LFT with Reduced Weight, Higher Rigidity, and Strong Damping

Feb 14, 2025

TOKYO,Feb. 13,2025-- Polyplastics Co.,Ltd.,a global leader in engineering plastics,has launched PLASTRON (R) LFT (long fiber-reinforced thermoplastic) RA627P,an eco-friendly composite of polypropylene

DAAN Biotherapeutics Signs Antibody Exclusive Licensing Agreement with LigaChem Biosciences for ADC (Antibody-Drug Conjugate) Therapeutic Development

Feb 14, 2025

SEOUL,South Korea,Feb. 13,2025-- DAAN Biotherapeutics,a leading innovative drug development company specializing in T-cell receptor (TCR)- based therapies,has signed an exclusive licensing agreement w

1 ... 80 81 82 83 84 85 86 ... 358